BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34389135)

  • 1. Technology Innovations in Continuous Kidney Replacement Therapy: The Clinician's Perspective.
    Szamosfalvi B; Heung M; Yessayan L
    Adv Chronic Kidney Dis; 2021 Jan; 28(1):3-12. PubMed ID: 34389135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating Shortages in Capacity to Deliver Continuous Kidney Replacement Therapy During the COVID-19 Pandemic in the United States.
    Reddy YNV; Walensky RP; Mendu ML; Green N; Reddy KP
    Am J Kidney Dis; 2020 Nov; 76(5):696-709.e1. PubMed ID: 32730812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialysis circuit clotting in critically ill patients with COVID-19 infection.
    Khoo BZE; Lim RS; See YP; Yeo SC
    BMC Nephrol; 2021 Apr; 22(1):141. PubMed ID: 33879086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semiautomated Regional Citrate Anticoagulation for Continuous Kidney Replacement Therapy: An Observational Study in Young Children.
    Liet JM; Baleine J; Demaret P; Mounier S; Porcheret F; Joram N; Chenouard A
    Pediatr Crit Care Med; 2022 Sep; 23(9):e429-e433. PubMed ID: 35583226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Criteria for Continuous Kidney Replacement Therapy Cessation in ICU Patients.
    Volbeda M; Oord M; Koeze J; Keus E; van der Horst ICC; Franssen CFM
    Blood Purif; 2023; 52(1):32-40. PubMed ID: 35439755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of nafamostat mesilate to citrate anticoagulation in pediatric continuous kidney replacement therapy.
    Miyaji MJ; Ide K; Takashima K; Maeno M; Krallman KA; Lazear D; Goldstein SL
    Pediatr Nephrol; 2022 Nov; 37(11):2733-2742. PubMed ID: 35348901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance and nutrition in neonatal continuous kidney replacement therapy using the Carpediem™ system.
    Vuong KT; Vega MR; Casey L; Swartz SJ; Srivaths P; Osborne SW; Rhee CJ; Arikan AA; Joseph C
    Pediatr Nephrol; 2024 Jun; 39(6):1937-1950. PubMed ID: 38231233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic disturbances and oliguria during continuous kidney replacement therapy in critically ill children.
    Fernández Lafever SN; López J; González R; Solana MJ; Urbano J; López-Herce J; Butragueño L; Santiago MJ
    Pediatr Nephrol; 2021 Jul; 36(7):1889-1899. PubMed ID: 33433709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-life effects, complications, and outcomes in 39 critically ill neonates receiving continuous kidney replacement therapy.
    Xu J; Fang L; Chen J; Chen X; Yang H; Zhang W; Wu L; Chen D
    Pediatr Nephrol; 2023 Sep; 38(9):3145-3152. PubMed ID: 36988692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study.
    Kameda S; Fujii T; Ikeda J; Kageyama A; Takagi T; Miyayama N; Asano K; Endo A; Uezono S
    BMC Nephrol; 2023 Jan; 24(1):12. PubMed ID: 36642717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of infants treated with CKRT: comparing adapted adult platforms with the Carpediem™.
    Goldstein SL; Vidal E; Ricci Z; Paglialonga F; Peruzzi L; Giordano M; Laforgia N; Ronco C
    Pediatr Nephrol; 2022 Mar; 37(3):667-675. PubMed ID: 34414499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current practices in pediatric continuous kidney replacement therapy: a systematic review-guided multinational modified Delphi consensus study.
    Fuhrman DY; Gist KM; Akcan-Arikan A
    Pediatr Nephrol; 2023 Aug; 38(8):2817-2826. PubMed ID: 36625932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of successful discontinuation of continuous kidney replacement therapy in a pediatric cohort.
    Wei EY; Vuong KT; Lee E; Liu L; Ingulli E; Coufal NG
    Pediatr Nephrol; 2023 Jul; 38(7):2221-2231. PubMed ID: 36315275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose of nafamostat mesylate during continuous kidney replacement therapy in critically ill patients: a two-centre observational study.
    Kameda S; Maeda A; Maeda S; Inoue Y; Takahashi K; Kageyama A; Doi K; Fujii T
    BMC Nephrol; 2024 Feb; 25(1):69. PubMed ID: 38408970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous Kidney Replacement Therapy and Survival in Children and Young Adults: Findings From the Multinational WE-ROCK Collaborative.
    Starr MC; Gist KM; Zang H; Ollberding NJ; Balani S; Cappoli A; Ciccia E; Joseph C; Kakajiwala A; Kessel A; Muff-Luett M; Santiago Lozano MJ; Pinto M; Reynaud S; Solomon S; Slagle C; Srivastava R; Shih WV; Webb T; Menon S;
    Am J Kidney Dis; 2024 Feb; ():. PubMed ID: 38364956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and Design of NEUTRALIZE-AKI: A Multicenter, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury Requiring Continuous Kidney Replacement Therapy.
    Yessayan L; Humes HD; Scribe EC; Iyer SPN; Chung KK
    Nephron; 2024; 148(1):43-53. PubMed ID: 37442112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous Kidney Replacement Therapy Practices in Pediatric Intensive Care Units Across Europe.
    Daverio M; Cortina G; Jones A; Ricci Z; Demirkol D; Raymakers-Janssen P; Lion F; Camilo C; Stojanovic V; Grazioli S; Zaoral T; Masjosthusmann K; Vankessel I; Deep A;
    JAMA Netw Open; 2022 Dec; 5(12):e2246901. PubMed ID: 36520438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous kidney replacement therapy in critically ill neonates and infants: a retrospective analysis of clinical results with a dedicated device.
    Garzotto F; Vidal E; Ricci Z; Paglialonga F; Giordano M; Laforgia N; Peruzzi L; Bellettato M; Murer L; Ronco C
    Pediatr Nephrol; 2020 Sep; 35(9):1699-1705. PubMed ID: 32440948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication patterns and dosing guidance in pediatric patients supported with intermittent hemodialysis or continuous kidney replacement therapy.
    McKnite AM; Green DJ; Nelson R; Brewer SC; Watt KM
    Pediatr Nephrol; 2024 May; 39(5):1521-1532. PubMed ID: 38051389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic instability during connection to continuous kidney replacement therapy in critically ill pediatric patients.
    Thadani S; Fogarty T; Mottes T; Price JF; Srivaths P; Bell C; Akcan-Arikan A
    Pediatr Nephrol; 2022 Sep; 37(9):2167-2177. PubMed ID: 35118547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.